These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1312 related articles for article (PubMed ID: 17573044)

  • 1. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.
    O'Reardon JP; Solvason HB; Janicak PG; Sampson S; Isenberg KE; Nahas Z; McDonald WM; Avery D; Fitzgerald PB; Loo C; Demitrack MA; George MS; Sackeim HA
    Biol Psychiatry; 2007 Dec; 62(11):1208-16. PubMed ID: 17573044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.
    Rumi DO; Gattaz WF; Rigonatti SP; Rosa MA; Fregni F; Rosa MO; Mansur C; Myczkowski ML; Moreno RA; Marcolin MA
    Biol Psychiatry; 2005 Jan; 57(2):162-6. PubMed ID: 15652875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial.
    Avery DH; Isenberg KE; Sampson SM; Janicak PG; Lisanby SH; Maixner DF; Loo C; Thase ME; Demitrack MA; George MS
    J Clin Psychiatry; 2008 Mar; 69(3):441-51. PubMed ID: 18294022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial.
    Matsuda Y; Kito S; Igarashi Y; Shigeta M
    Neuropsychobiology; 2020; 79(3):208-213. PubMed ID: 31955155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial.
    Huang ML; Luo BY; Hu JB; Wang SS; Zhou WH; Wei N; Hu SH; Xu Y
    Aust N Z J Psychiatry; 2012 Mar; 46(3):257-64. PubMed ID: 22391283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The painfulness of active, but not sham, transcranial magnetic stimulation decreases rapidly over time: results from the double-blind phase of the OPT-TMS Trial.
    Borckardt JJ; Nahas ZH; Teal J; Lisanby SH; McDonald WM; Avery D; Durkalski V; Pavlicova M; Long JM; Sackeim HA; George MS
    Brain Stimul; 2013 Nov; 6(6):925-8. PubMed ID: 23769413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder.
    Rosenquist PB; Krystal A; Heart KL; Demitrack MA; McCall WV
    Psychiatry Res; 2013 Jan; 205(1-2):67-73. PubMed ID: 23021320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression.
    Leuchter AF; Cook IA; Feifel D; Goethe JW; Husain M; Carpenter LL; Thase ME; Krystal AD; Philip NS; Bhati MT; Burke WJ; Howland RH; Sheline YI; Aaronson ST; Iosifescu DV; O'Reardon JP; Gilmer WS; Jain R; Burgoyne KS; Phillips B; Manberg PJ; Massaro J; Hunter AM; Lisanby SH; George MS
    Brain Stimul; 2015; 8(4):787-94. PubMed ID: 26143022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial.
    Fitzgerald PB; Brown TL; Marston NA; Daskalakis ZJ; De Castella A; Kulkarni J
    Arch Gen Psychiatry; 2003 Oct; 60(10):1002-8. PubMed ID: 14557145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcranial magnetic stimulation (TMS) in the treatment of attention-deficit/hyperactivity disorder in adolescents and young adults: a pilot study.
    Weaver L; Rostain AL; Mace W; Akhtar U; Moss E; O'Reardon JP
    J ECT; 2012 Jun; 28(2):98-103. PubMed ID: 22551775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of major depression with bilateral theta burst stimulation: a randomized controlled pilot trial.
    Plewnia C; Pasqualetti P; Große S; Schlipf S; Wasserka B; Zwissler B; Fallgatter A
    J Affect Disord; 2014 Mar; 156():219-23. PubMed ID: 24411682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.
    Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP
    J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression.
    Avery DH; Holtzheimer PE; Fawaz W; Russo J; Neumaier J; Dunner DL; Haynor DR; Claypoole KH; Wajdik C; Roy-Byrne P
    Biol Psychiatry; 2006 Jan; 59(2):187-94. PubMed ID: 16139808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PsychotherapyPlus: augmentation of cognitive behavioral therapy (CBT) with prefrontal transcranial direct current stimulation (tDCS) in major depressive disorder-study design and methodology of a multicenter double-blind randomized placebo-controlled trial.
    Bajbouj M; Aust S; Spies J; Herrera-Melendez AL; Mayer SV; Peters M; Plewnia C; Fallgatter AJ; Frase L; Normann C; Behler N; Wulf L; Brakemeier EL; Padberg F
    Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):797-808. PubMed ID: 29214483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive outcomes of transcranial magnetic stimulation in treatment-resistant depression: a randomized controlled study.
    Yıldız T; Oğuzhanoğlu NK; Topak OZ
    Turk J Med Sci; 2023 Feb; 53(1):253-263. PubMed ID: 36945926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial with 4-month follow-up of adjunctive repetitive transcranial magnetic stimulation of the left prefrontal cortex for depression.
    Mogg A; Pluck G; Eranti SV; Landau S; Purvis R; Brown RG; Curtis V; Howard R; Philpot M; McLoughlin DM
    Psychol Med; 2008 Mar; 38(3):323-33. PubMed ID: 17935639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of transcranial magnetic stimulation in pregnant women with major depressive disorder.
    Kim DR; Wang E; McGeehan B; Snell J; Ewing G; Iannelli C; O'Reardon JP; Sammel MD; Epperson CN
    Brain Stimul; 2019; 12(1):96-102. PubMed ID: 30249416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.